Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John K. Bell currently holds 17,601 shares of DelMar Pharmaceuticals, Inc. (DMPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John K. Bell has been a net buyer of DMPI stock. They have purchased $213.8K and sold $0 worth of shares.
John K. Bell's most recent insider trade was on Aug 20, 2020, when they sold 17,601 shares at $0.00 per share.
John K. Bell serves as Executive at DelMar Pharmaceuticals, Inc. (DMPI). They have executed 33 insider transactions totaling $213.8K over their tenure at the company.
John K. Bell holds the position of Executive at DelMar Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
John K. Bell has shown a buying trading pattern, with $213.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by John K. Bell was on Mar 18, 2014, when they purchased $32.5K worth of DMPI shares. This transaction involved 25,000 shares at $1.30 per share.
John K. Bell currently owns 17,601 shares of DelMar Pharmaceuticals, Inc. (DMPI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John K. Bell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John K. Bell has 33 Form 4 filings on record as an insider at DelMar Pharmaceuticals, Inc..
Set alerts for John K. Bell and 40,000+ other insiders.